NASDAQ:NXL

Nexalin Technology Q2 2026 Earnings Results & Report

Nexalin Technology logo
$1.44 -0.06 (-4.00%)
Closing price 11/18/2026 03:58 PM Eastern
Extended Trading
$1.51 +0.07 (+4.86%)
As of 11/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nexalin Technology beat analyst earnings expectations but missed on revenue in its Q2 2026 results, released August 12, 2026. The company reported EPS of -$0.11 versus the -$3.00 consensus estimate, while revenue of $12.16 thousand fell short of the $90 thousand estimate by $77.84 thousand.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
Before Market Opens
Conference Call
7:00 AM ET

Nexalin Technology EPS Results

Actual EPS
-$0.11
Consensus EPS
-$3.00
Beat/Miss
Beat by +$2.89
One Year Ago EPS
N/A
EPS Beat Rate
2 of last 7 quarters

Nexalin Technology Revenue Results

Actual Revenue
$12.16 thousand
Expected Revenue
$90 thousand
Beat/Miss
Missed by -$77.84 thousand
YoY Revenue Growth
N/A

Earnings Documents

Nexalin Technology Q2 2026 Earnings FAQ

Nexalin Technology (NASDAQ:NXL) reported earnings of -$0.11 per share for Q2 2026, beating the consensus estimate of -$3.00. The report was announced on Wednesday, August 12, 2026.

Nexalin Technology reported revenue of $12.16 thousand for Q2 2026, against a consensus estimate of $90 thousand.

Nexalin Technology Earnings Headlines

Your $7 scanner is waiting
The Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which stock, what price, and when to exit. The list reads the same whether you've traded for twenty years or twenty days, and it doesn't depend on account size. If it's not for you, refund the $7 and still keep the scanner for the full year. One payment, no re-bills.tc pixel
NXL - Nexalin Technology, Inc.
See More Nexalin Technology Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nexalin Technology? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nexalin Technology and other key companies, straight to your email.

About Nexalin Technology

Nexalin Technology (NASDAQ:NXL) develops non-invasive neurostimulation devices for behavioral health applications. Its technology delivers low-level electrical signals through electrodes placed on the head, with the aim of supporting care for conditions such as anxiety, depression and insomnia.

The company’s product line includes its Gen-2 and Gen-3 cranial electrotherapy stimulation devices. Nexalin focuses on developing and commercializing these systems for use by healthcare providers and patients, and has pursued regulatory clearances and distribution opportunities in the United States and international markets.

View Nexalin Technology Profile